WallStreetZenWallStreetZen

NASDAQ: SNDX
Syndax Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SNDX past revenue growth

How has SNDX's revenue growth performed historically?
Company
N/A
Industry
148.64%
Market
17.33%
SNDX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNDX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

SNDX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$209.4M
Current Profit Margin
0%

SNDX Return on Equity

Current Company
-47.9%
Current Industry
-63.5%
Current Market
188%
SNDX's Return on Equity (-47.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SNDX announces earnings.

SNDX Return on Assets

Current Company
-44%
Current Industry
2.9%
SNDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SNDX Return on Capital Employed

Current Company
-37.7%
Current Industry
19.5%
SNDX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SNDX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SNDX$0.00-$208.40M-$209.36M-100.00%N/A
SANA$0.00-$245.43M-$283.26MN/AN/A
AGIO$26.82M-$334.75M-$352.09M-22.25%N/A
RXRX$44.58M-$299.66M-$328.07M+109.39%N/A
FUSN$2.07M-$85.08M-$94.90M+19.84%N/A
View Top Biotech Stocks

SNDX earnings dates

Next earnings date
May 6, 2024

Syndax Pharmaceuticals Earnings & Revenue FAQ

What were SNDX's earnings last quarter?

On Invalid Date, Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q4 2023 earnings per share (EPS) of -$1.01, up 62.9% year over year. Total Syndax Pharmaceuticals earnings for the quarter were -$72.47 million. In the same quarter last year, Syndax Pharmaceuticals's earnings per share (EPS) was -$0.62.

If you're new to stock investing, here's how to buy Syndax Pharmaceuticals stock.

What was SNDX's earnings growth in the past year?

As of Q2 2024, Syndax Pharmaceuticals's earnings has grown year over year. Syndax Pharmaceuticals's earnings in the past year totalled -$209.36 million.

What is SNDX's earnings date?

Syndax Pharmaceuticals's earnings date is Invalid Date. Add SNDX to your watchlist to be reminded of SNDX's next earnings announcement.

What was SNDX's revenue last quarter?

On Invalid Date, Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Syndax Pharmaceuticals's revenue was $0.00.

What was SNDX's revenue growth in the past year?

As of Q2 2024, Syndax Pharmaceuticals's revenue has grown null year over year. Syndax Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.